TERESTIGMINE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C21H33N3O3
Molecular Weight	375.505
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCCCCCCNC(=O)OC1=CC2=C(C=C1)N(C)[C@H]3ON(C)CC[C@@]23C

InChI

InChIKey=AFVACNVFXZVAEU-FPOVZHCZSA-N

InChI=1S/C21H33N3O3/c1-5-6-7-8-9-13-22-20(25)26-16-10-11-18-17(15-16)21(2)12-14-23(3)27-19(21)24(18)4/h10-11,15,19H,5-9,12-14H2,1-4H3,(H,22,25)/t19-,21-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C21H33N3O3
Molecular Weight	375.505
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://patents.google.com/patent/WO2011151359A1/en | https://adisinsight.springer.com/drugs/800003653

Terestigmine (also known as CHF-2060), a cholinesterase inhibitor, was developed for the treatment of cognition disorders in Italy. However, this study was discontinued.

Originator

Approval Year

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:15:53 GMT 2025` Edited by `admin` on `Mon Mar 31 18:15:53 GMT 2025`
Record UNII	9EG92T3EQE
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

(4AS,9AS)-2,3,4,4A,9,9A-HEXAHYDRO-2,4A,9-TRIMETHYL-1,2-OXAZINO(6,5-B)INDOL-6-YL HEPTYLCARBAMATE

Preferred Name

English

TERESTIGMINE

Official Name

English

terestigmine [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C47792